Two Sigma Advisers’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.72M | Sell |
171,400
-35,200
| -17% | -$1.79M | 0.02% | 551 |
|
|
2025
Q1 | $9.31M | Buy |
206,600
+32,200
| +18% | +$1.45M | 0.02% | 555 |
|
|
2024
Q4 | $7.21M | Sell |
174,400
-31,100
| -15% | -$1.29M | 0.02% | 578 |
|
|
2024
Q3 | $8.01M | Buy |
205,500
+25,600
| +14% | +$998K | 0.02% | 550 |
|
|
2024
Q2 | $6.15M | Sell |
179,900
-17,100
| -9% | -$585K | 0.01% | 687 |
|
|
2024
Q1 | $4.95M | Sell |
197,000
-139,300
| -41% | -$3.5M | 0.01% | 782 |
|
|
2023
Q4 | $9.93M | Sell |
336,300
-54,600
| -14% | -$1.61M | 0.02% | 530 |
|
|
2023
Q3 | $12.4M | Buy |
390,900
+328,300
| +524% | +$10.4M | 0.03% | 412 |
|
|
2023
Q2 | $1.62M | Buy |
62,600
+32,300
| +107% | +$836K | ﹤0.01% | 1306 |
|
|
2023
Q1 | $728K | Sell |
30,300
-49,500
| -62% | -$1.19M | ﹤0.01% | 1782 |
|
|
2022
Q4 | $1.56M | Sell |
79,800
-32,100
| -29% | -$626K | ﹤0.01% | 1367 |
|
|
2022
Q3 | $2.35M | Sell |
111,900
-46,100
| -29% | -$969K | 0.01% | 1088 |
|
|
2022
Q2 | $3.08M | Sell |
158,000
-45,800
| -22% | -$891K | 0.01% | 988 |
|
|
2022
Q1 | $4.49M | Buy |
203,800
+36,058
| +21% | +$794K | 0.01% | 838 |
|
|
2021
Q4 | $2.68M | Buy |
167,742
+74,242
| +79% | +$1.18M | 0.01% | 1048 |
|
|
2021
Q3 | $1.86M | Buy |
93,500
+11,700
| +14% | +$233K | ﹤0.01% | 1298 |
|
|
2021
Q2 | $1.41M | Buy |
81,800
+12,600
| +18% | +$218K | ﹤0.01% | 1474 |
|
|
2021
Q1 | $1.37M | Buy |
69,200
+46,100
| +200% | +$914K | ﹤0.01% | 1465 |
|
|
2020
Q4 | $403K | Buy |
+23,100
| New | +$403K | ﹤0.01% | 1946 |
|